Hepatocrinology

Hepatocrinology

Hepatocrinology is defined as a bidirectional, complex relationship between hepatic physiology and endocrine function, hepatic disease and endocrine dysfunction, hepatotropic drugs and endocrine function, and endocrine drugs and hepatic health. The scope of hepatocrinology includes conditions of var...

Full description

Bibliographic Details
Main Authors:	Sanjay Kalra, Saptarshi Bhattacharya, Pawan Rawal
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Medical Sciences
Subjects:	cirrhosis diabetes endocrine hepatogenous diabetes liver NAFLD
Online Access:	https://www.mdpi.com/2076-3271/9/2/39

Similar Items

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
by: Angelo Armandi, et al.
Published: (2021-03-01)

“Hepatogenic diabetes” is an old term and new meaning
by: Yu. Kokovina, et al.
Published: (2020-05-01)

Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network
by: Marina Farah, et al.
Published: (2023-03-01)

Disorder of Glucose Metabolism and Therapy: Implications on the Natural History of Advanced Chronic Liver Disease
by: Sofia Garcês Soares, et al.
Published: (2024-10-01)

High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia
by: Patricia C. Valery, et al.
Published: (2024-04-01)

Therapeutic Physical Exercise Programs in the Context of NASH Cirrhosis and Liver Transplantation: A Systematic Review
by: Marwin A. Farrugia, et al.
Published: (2023-02-01)

Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population
by: Pratyush Kumar, et al.
Published: (2022-01-01)

Unraveling the Association of Liver Steatosis and Fibrosis with Vitamin B12: A Cross-Sectional Study
by: Silvia Espina, et al.
Published: (2024-11-01)

Monitoring endocrine nursing in South Asia (MENSA)
by: Sunetra Mondal, et al.
Published: (2023-01-01)

Determination of Frequency of Diabetes and Pre-Diabetes in Patients with Nonalcoholic Fatty Liver Disease and Comparison with a Control Group
by: Bahram Pakzad, et al.
Published: (2016-03-01)

Physical frailty, genetic predisposition, and the risks of severe non‐alcoholic fatty liver disease and cirrhosis: a cohort study
by: Honghao Yang, et al.
Published: (2024-08-01)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
by: Yi-Te Lee, et al.
Published: (2023-04-01)

Hepatogenic weakness as a clinical marker of hyperammonemia and of the effectiveness of its correction in patients with pre-cirrhotic stages of non-alcoholic fatty liver disease
by: E. M. Petrova, et al.
Published: (2021-06-01)

NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
by: Simona Cernea
Published: (2024-02-01)

Association between antidepressant use and liver fibrosis in patients with type 2 diabetes: a population based study
by: Lin Shi, et al.
Published: (2023-03-01)

ETIOLOGICAL SPECTRUM OF CIRRHOSIS IN ANAND DISTRICT, GUJARAT, INDIA
by: Sulabhsinh G Solanki, et al.
Published: (2017-03-01)

Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases
by: Dimitrina Miteva, et al.
Published: (2023-11-01)

From NAFLD to Chronic Liver Diseases. Assessment of Liver Fibrosis through Non-Invasive Methods before Liver Transplantation: Can We Rely on Them?
by: Pasquale Auricchio, et al.
Published: (2023-05-01)

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries
by: Isabel Graupera, et al.
Published: (2022-07-01)

Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study
by: Syed Mushfiq, et al.
Published: (2025-01-01)

Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review
by: Madalena Von-Hafe, et al.
Published: (2022-03-01)

Estimating the cost of illness of non‐alcoholic fatty liver disease in Bangladesh
by: Shahinul Alam, et al.
Published: (2023-09-01)

Sarcopenic obesity in liver disease: Handling both sides of the penny
by: Yangyang Hui, et al.
Published: (2022-06-01)

Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
by: Kristine Griffett, et al.
Published: (2023-02-01)

Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease
by: Jingjing Jiao, et al.
Published: (2023-02-01)

Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis
by: Tanat Yongpisarn, et al.
Published: (2022-12-01)

Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer
by: Elizabeth E Powell, et al.
Published: (2024-07-01)

Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy
by: Alberto Ferrarese, et al.
Published: (2022-02-01)

Efficacy and safety of saroglitazar in real‐world patients of non‐alcoholic fatty liver disease with or without diabetes including compensated cirrhosis: A tertiary care center experience
by: Sujit Chaudhuri, et al.
Published: (2023-03-01)

Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)
by: James M. Paik, et al.
Published: (2023-07-01)

A nationwide population-based prospective study of cirrhosis in Iceland
by: Sigurdur Olafsson, et al.
Published: (2021-06-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Experimental poisoning by Brachiaria decumbens in rabbits
by: Kiyoko U. Utiumi, et al.

Trend of Non-Alcoholic Fatty Liver Disease in Type II Diabetes Mellitus
by: Fariha Khan, et al.
Published: (2024-05-01)

The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: Chia-Yen Dai, et al.
Published: (2022-06-01)

Metabolic dysfunction: The silenced connection with fatty liver disease
by: Mariana M. Ramírez-Mejía, et al.
Published: (2023-11-01)

Effects of Moringa oleifera Leaf Extract on the Liver of Experimentally-Induced Diabetic Wistar Rats
by: Wahyu Ikhsan, et al.
Published: (2023-06-01)

Screening strategy for non-alcoholic fatty liver disease
by: Saisai Zhang, et al.
Published: (2023-02-01)

Liver transplantation on the occasion biliary cirrhosis in the patient with diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2011-09-01)

Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
by: Michael H. Le, et al.
Published: (2024-04-01)